A carregar...
Lofexidine for acute opioid withdrawal: A clinical case series
INTRODUCTION: Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmatic studies describing its use in clinical practice...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534813/ https://ncbi.nlm.nih.gov/pubmed/33062550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2020.09.259 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|